^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    MSH3 overexpression

    i
    Other names: MSH3, MutS Homolog 3, Divergent Upstream Protein, Mismatch Repair Protein 1, DNA Mismatch Repair Protein Msh3, HMSH3, MRP1, DUP, Epididymis Secretory Sperm Binding Protein, MutS (E. Coli) Homolog 3, MutS Homolog 3 (E. Coli), FAP4, DUC1, DUG
    Entrez ID:
    4437
    Related biomarkers:
    Mutation
    over1year
    Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infiltration, and development of DRG prognostic prediction model in RCC, in which MSH3 is a key gene during disulfidptosis. (PubMed, Front Immunol)
    In addition, this study has successfully established a new disulfidptosis-related genes prediction model and discovered a key gene MSH3. They may be new prognostic biomarkers for RCC patients, provide new insights for the treatment of RCC patients, and may inspire new methods for the diagnosis and treatment of RCC patients.
    Journal • IO biomarker
    |
    MSH3 (MutS Homolog 3)
    |
    MSH3 overexpression
    over2years
    The CtIP-CtBP1/2-HDAC1-AP1 transcriptional complex is required for the transrepression of DNA damage modulators in the pathogenesis of osteosarcoma. (PubMed, Transl Oncol)
    Overexpression of MLH1, MSH3, BRCA1, or CDKN1A in osteosarcoma cells can reduce cell viability, colony formation, cell migration, and tumor growth. Our findings suggest that the CtIP-CtBP1/2-HDAC1-AP1 complex is required for mediation of DNA damage processes for the pathogenesis of osteosarcoma.
    Journal • BRCA Biomarker
    |
    BRCA1 (Breast cancer 1, early onset) • MLH1 (MutL homolog 1) • MSH3 (MutS Homolog 3) • RBBP8 (RB Binding Protein 8, Endonuclease) • HDAC1 (Histone Deacetylase 1) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • CTBP1 (C-Terminal Binding Protein 1)
    |
    BRCA1 expression • MSH3 overexpression